Skip to main content
Signal8

BriaCell Therapeutics Corp. (BCTX) Form 424B5 — Jun 2, 2026

$BCTXForm 424B5Filed Jun 2, 2026, 8:00 AM ET0001493152-26-026759Original filing

BriaCell Therapeutics Corp. (BCTX) is offering 1,449,300 common shares at $3.25 per share, raising approximately $4.7 million in gross proceeds. The offering price represents a 10.7% discount to the last reported market price of $3.64 on May 29, 2026, signaling immediate downward pressure on the stock. New investors will face immediate dilution of $0.66 per share, as the offering price is below the company's pro forma net tangible book value of $3.91 per share.

Key figures

Net Proceeds
3940000
Total Assets
33594454
Cash Position
29903628
Gross Proceeds
4710225
Offering Price
3.25
Shares Offered
1449300
Dilution Per Share
0.66
Public Float Value
33500000
Last Reported Price
3.64
Placement Agent Fee Percent
7.5
Shares Outstanding Post Offering
8699787

Price after filing

1 day: +1.2%7 days: -6.1%30 days: +6.1%

Close on the filing date to close N calendar days later (from $3.27). Historical, not a forecast.

AI analysis

Red flags7 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    BriaCell Therapeutics Corp. (BCTX) Form 424B5 — Jun 2, 2026: AI Analysis | Signal8